Narrative updates are currently in beta.

Back to narrative

Update shared on19 Aug 2025

Fair value Decreased 7.67%
AnalystConsensusTarget's Fair Value
₹1,967.82
8.2% undervalued intrinsic discount
20 Aug
₹1,805.75
Loading
1Y
-36.0%
7D
-2.7%

Despite a stronger revenue growth outlook, Deepak Nitrite's consensus price target was revised downward to ₹2013 primarily due to a decline in net profit margin.


What's in the News


  • Board meeting scheduled to approve Q1 FY26 standalone and consolidated unaudited financial results.
  • Entered a three-year exclusive purchase and marketing agreement with Chemcrux Enterprises for Para Nitro Benzoic Acid (PNBA); Deepak Nitrite and subsidiary to supply raw materials, Chemcrux to manufacture PNBA, and Deepak Nitrite to market the product.

Valuation Changes


Summary of Valuation Changes for Deepak Nitrite

  • The Consensus Analyst Price Target has fallen from ₹2131 to ₹2013.
  • The Consensus Revenue Growth forecasts for Deepak Nitrite has significantly risen from 11.3% per annum to 13.6% per annum.
  • The Net Profit Margin for Deepak Nitrite has fallen from 9.36% to 8.80%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.